Jove
Visualize
Contact Us

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

557
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
557
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

10.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Special Issue "Molecules at Play in Neurological Diseases".

Current issues in molecular biology·2025
Same author

Neurotransmission Sex Dichotomy in the Rat Hypothalamic Paraventricular Nucleus in Healthy and Infantile Spasm Model.

Current issues in molecular biology·2025
Same author

Papillary Thyroid Cancer Remodels the Genetic Information Processing Pathways.

Genes·2024
Same author

Advanced Molecular Solutions for Cancer Therapy-The Good, the Bad, and the Ugly of the Biomarker Paradigm.

Current issues in molecular biology·2024
Same author

Genomic Fabrics of the Excretory System's Functional Pathways Remodeled in Clear Cell Renal Cell Carcinoma.

Current issues in molecular biology·2023
Same author

Metabolic Deregulation in Pulmonary Hypertension.

Current issues in molecular biology·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 6, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

674

Powerful quantifiers for cancer transcriptomics.

Dumitru Andrei Iacobas1

  • 1Personalized Genomics Laboratory, CRI Center for Computational Systems Biology, Roy G Perry College of Engineering, Prairie View A&M University, Prairie View, TX 77446, United States. daiacobas@pvamu.edu.

World Journal of Clinical Oncology
|October 9, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces a novel approach to cancer analysis by utilizing gene expression variability and coordination, not just average levels. This method identifies key cancer gene regulators for personalized gene therapy, offering a more targeted treatment strategy.

Keywords:
Cancer biomarkersCancer noduleGene therapyKidney cancerProstate cancerRNA geneThyroid cancer

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.8K

Related Experiment Videos

Last Updated: Dec 6, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

674
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.8K

Area of Science:

  • Genomics and Bioinformatics
  • Cancer Biology
  • Translational Medicine

Background:

  • Cancer is characterized by alterations in gene sequence and expression, leading to the identification of gene biomarkers.
  • Current cancer diagnostics often focus on single gene mutations or expression levels, overlooking the broader transcriptomic landscape.
  • Cancer involves complex gene interactions, not just individual gene behavior, necessitating a more comprehensive analysis.

Purpose of the Study:

  • To quantify transcriptomic changes during cancer progression and treatment response using average expression, variability, and co-expression patterns.
  • To identify influential genes, termed Gene Master Regulators (GMRs), within cancer tissues.
  • To propose a personalized medicine approach by targeting cancer-specific GMRs for therapeutic intervention.

Main Methods:

  • Utilized microarray data from surgically removed tumors, analyzing cancer nodules and surrounding normal tissue.
  • Applied a novel analytical framework incorporating average gene expression, expression variability, and gene-gene expression coordination.
  • Developed a mathematical algorithm to identify GMRs and assess their influence in different tissue types.

Main Results:

  • Transcriptomic profiles (topologies) differ significantly across histologically distinct tumor regions and are unique to each individual.
  • Identified specific Gene Master Regulators (GMRs) that are highly influential in cancer nodules but less so in normal tissue.
  • Demonstrated that transcriptomic features are dynamic, changing with disease progression and in response to treatment.

Conclusions:

  • A personalized approach to cancer medicine is recommended, leveraging comprehensive transcriptomic data beyond average expression levels.
  • Targeting cancer-specific GMRs offers a promising strategy for selective cancer cell elimination with minimal impact on normal cells.
  • The study presents a viable experimental and computational framework for identifying GMRs for effective gene therapy.